Free Trial

GoHealth, Inc. (NASDAQ:GOCO) Short Interest Down 10.6% in November

GoHealth logo with Finance background

GoHealth, Inc. (NASDAQ:GOCO - Get Free Report) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 168,000 shares, a decline of 10.6% from the November 15th total of 187,900 shares. Based on an average trading volume of 25,000 shares, the days-to-cover ratio is presently 6.7 days. Currently, 2.0% of the company's stock are sold short.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada restated a "sector perform" rating and set a $13.00 price target on shares of GoHealth in a report on Monday, October 21st.

Read Our Latest Report on GOCO

GoHealth Stock Performance

Shares of GOCO traded up $2.06 on Tuesday, reaching $12.61. 200,161 shares of the company's stock traded hands, compared to its average volume of 20,990. The stock's 50 day simple moving average is $11.31 and its two-hundred day simple moving average is $10.46. The stock has a market cap of $288.84 million, a PE ratio of -3.57 and a beta of 1.69. GoHealth has a 52-week low of $7.27 and a 52-week high of $16.44. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.72.

Institutional Investors Weigh In On GoHealth

A number of hedge funds have recently made changes to their positions in GOCO. Empowered Funds LLC increased its stake in shares of GoHealth by 5.1% during the 3rd quarter. Empowered Funds LLC now owns 22,048 shares of the company's stock worth $207,000 after purchasing an additional 1,072 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in GoHealth by 16.1% during the second quarter. Bank of New York Mellon Corp now owns 12,982 shares of the company's stock valued at $126,000 after purchasing an additional 1,802 shares during the period. Geode Capital Management LLC increased its position in GoHealth by 3.2% in the third quarter. Geode Capital Management LLC now owns 103,735 shares of the company's stock worth $973,000 after buying an additional 3,205 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of GoHealth by 22.0% in the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company's stock valued at $178,000 after buying an additional 3,300 shares during the period. Finally, Barclays PLC raised its stake in shares of GoHealth by 83.9% in the third quarter. Barclays PLC now owns 9,580 shares of the company's stock valued at $89,000 after buying an additional 4,372 shares during the period. 24.21% of the stock is currently owned by institutional investors.

About GoHealth

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Featured Articles

Should you invest $1,000 in GoHealth right now?

Before you consider GoHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.

While GoHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines